As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months.  The ACCME defines a “commercial interest” as any entity producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients.  The ACCME does not consider providers of clinical service directly to patients to be commercial interests.  For more information, visit www.accme.org.  All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity and appropriateness of patient care recommendations.  It is required that disclosure be provided to the learners prior to the start of the activity.

Individuals with no relevant financial relationships exist.  Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality.  It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.  Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Jay Portnoy, MD (Planner)

Speaker, honorarium: Thermofisher, Boehringer Ingelheim

The following have no financial relationships to disclose:

Paul Dowling MD (Planner)

Justin Greiwe, MD (Speaker)